Point72 Hong Kong Ltd Buys 10,280 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Point72 Hong Kong Ltd raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 114.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 19,230 shares of the medical equipment provider’s stock after purchasing an additional 10,280 shares during the period. Point72 Hong Kong Ltd’s holdings in Intuitive Surgical were worth $10,037,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical in the 4th quarter valued at about $82,517,000. Sycomore Asset Management increased its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares in the last quarter. Finally, Truist Financial Corp increased its position in Intuitive Surgical by 3.0% in the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock valued at $129,494,000 after buying an additional 7,298 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Evercore ISI decreased their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Piper Sandler decreased their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Trading Up 0.4%

Shares of NASDAQ ISRG opened at $565.94 on Thursday. The firm has a market cap of $202.84 billion, a price-to-earnings ratio of 88.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The stock has a fifty day simple moving average of $502.26 and a two-hundred day simple moving average of $535.79. Intuitive Surgical, Inc. has a 1-year low of $386.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the sale, the chief financial officer now directly owns 7,162 shares of the company’s stock, valued at approximately $4,060,424.28. The trade was a 2.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,680 shares of company stock worth $16,854,345. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.